SEC Filing Summary for Adicet Bio, Inc. (ACET) - Insider Transaction

This filing details a transaction by Steve Dubin, a director at Adicet Bio, Inc. On June 21, 2026, Mr. Dubin acquired 4,200 stock options for $0.00 per share, with an exercise price of $8.10. These options are exercisable and will vest fully on the earlier of the first anniversary of the grant date or the next annual meeting of stockholders, provided Mr. Dubin continues his service on the board. The options are for the company's Common Stock and expire on June 20, 2036. Following this transaction, Mr. Dubin directly owns 4,200 shares.